Algernon Pharmaceuticals Inc.
AGN
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -414.80K | -260.10K | -277.00K | -307.70K | 1.06M |
| Total Depreciation and Amortization | 6.20K | 4.20K | 4.00K | 3.90K | 4.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 141.90K | 22.30K | 13.40K | 3.40K | -1.36M |
| Change in Net Operating Assets | 142.60K | 59.30K | 82.20K | -161.40K | -1.02M |
| Cash from Operations | -124.10K | -174.30K | -177.40K | -461.90K | -1.31M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 124.50K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -10.60K | -- | -2.90K | 1.69M |
| Cash from Investing | 124.50K | -10.60K | -- | -2.90K | 1.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 200.00 | 341.60K | 7.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 286.50K | -- |
| Cash from Financing | 0.00 | 0.00 | 200.00 | 458.60K | 5.50K |
| Foreign Exchange rate Adjustments | -3.20K | -800.00 | 4.00K | -3.50K | 3.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.80K | -185.70K | -173.20K | -9.70K | 391.30K |